Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Research Report 2025(Status and Outlook)
Description
Report Overview
The basic principle of chimeric antigen receptor T cell immunotherapy is to use the patient’s own immune cells to eliminate cancer cells. Among them, chimeric antigen receptor (CAR) is the core component of CAR-T, giving T cells HLA-independent recognition The ability of tumor antigens, which enables CAR-modified T cells to recognize a wider range of targets than the natural T cell surface receptor TCR. The basic design of CAR includes a tumor-associated antigen (TAA) binding region (usually derived from the scFV segment of the monoclonal antibody antigen binding region), an extracellular hinge region, a transmembrane region and an intracellular signal Area
This report provides a deep insight into the global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market in any manner.
Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Novartis
Bristol Myers Squibb
Legend Biotech
Sorrento Therapeutics
CARSGEN Therapeutics，Ltd
Juno Therapeutics
Kite Pharma
Atara Biotherapeutics
Carina Biotech
Guangzhou Xiangxue Pharmaceutical
Market Segmentation (by Type)
Allogeneic CAR T-Cells
Autologous CAR T-Cells
Market Segmentation (by Application)
Hospital
Diagnostic Center
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market
Overview of the regional outlook of the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The basic principle of chimeric antigen receptor T cell immunotherapy is to use the patient’s own immune cells to eliminate cancer cells. Among them, chimeric antigen receptor (CAR) is the core component of CAR-T, giving T cells HLA-independent recognition The ability of tumor antigens, which enables CAR-modified T cells to recognize a wider range of targets than the natural T cell surface receptor TCR. The basic design of CAR includes a tumor-associated antigen (TAA) binding region (usually derived from the scFV segment of the monoclonal antibody antigen binding region), an extracellular hinge region, a transmembrane region and an intracellular signal Area
This report provides a deep insight into the global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market in any manner.
Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Novartis
Bristol Myers Squibb
Legend Biotech
Sorrento Therapeutics
CARSGEN Therapeutics，Ltd
Juno Therapeutics
Kite Pharma
Atara Biotherapeutics
Carina Biotech
Guangzhou Xiangxue Pharmaceutical
Market Segmentation (by Type)
Allogeneic CAR T-Cells
Autologous CAR T-Cells
Market Segmentation (by Application)
Hospital
Diagnostic Center
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market
Overview of the regional outlook of the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Table of Contents
175 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
- 1.2 Key Market Segments
- 1.2.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Segment by Type
- 1.2.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Life Cycle
- 3.3 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Manufacturers (2020-2025)
- 3.4 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Manufacturing Sites, Area Served, Product Type
- 3.8 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Competitive Situation and Trends
- 3.8.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Chain Analysis
- 4.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 Global Trade Frictions and Their Impacts to Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market
- 5.7 ESG Ratings of Leading Companies
- 6 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Type (2020-2025)
- 6.3 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2020-2025)
- 6.4 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Price by Type (2020-2025)
- 7 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Sales by Application (2020-2025)
- 7.3 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (M USD) by Application (2020-2025)
- 7.4 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Growth Rate by Application (2020-2025)
- 8 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Sales by Region
- 8.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Region
- 8.1.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Region
- 8.1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Market Share by Region
- 8.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region
- 8.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region
- 8.2.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Country
- 8.3.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Country
- 8.4.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Region
- 8.5.2 Asia Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Country
- 8.6.2 South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Region
- 8.7.2 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Production by Region
- 9.1 Global Production of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Region(2020-2025)
- 9.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Region (2020-2025)
- 9.3 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production
- 9.4.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Growth Rate (2020-2025)
- 9.4.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production
- 9.5.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Growth Rate (2020-2025)
- 9.5.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production (2020-2025)
- 9.6.1 Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Growth Rate (2020-2025)
- 9.6.2 Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production (2020-2025)
- 9.7.1 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Growth Rate (2020-2025)
- 9.7.2 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Pfizer
- 10.1.1 Pfizer Basic Information
- 10.1.2 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Overview
- 10.1.3 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Market Performance
- 10.1.4 Pfizer Business Overview
- 10.1.5 Pfizer SWOT Analysis
- 10.1.6 Pfizer Recent Developments
- 10.2 Novartis
- 10.2.1 Novartis Basic Information
- 10.2.2 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Overview
- 10.2.3 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Market Performance
- 10.2.4 Novartis Business Overview
- 10.2.5 Novartis SWOT Analysis
- 10.2.6 Novartis Recent Developments
- 10.3 Bristol Myers Squibb
- 10.3.1 Bristol Myers Squibb Basic Information
- 10.3.2 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Overview
- 10.3.3 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Market Performance
- 10.3.4 Bristol Myers Squibb Business Overview
- 10.3.5 Bristol Myers Squibb SWOT Analysis
- 10.3.6 Bristol Myers Squibb Recent Developments
- 10.4 Legend Biotech
- 10.4.1 Legend Biotech Basic Information
- 10.4.2 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Overview
- 10.4.3 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Market Performance
- 10.4.4 Legend Biotech Business Overview
- 10.4.5 Legend Biotech Recent Developments
- 10.5 Sorrento Therapeutics
- 10.5.1 Sorrento Therapeutics Basic Information
- 10.5.2 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Overview
- 10.5.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Market Performance
- 10.5.4 Sorrento Therapeutics Business Overview
- 10.5.5 Sorrento Therapeutics Recent Developments
- 10.6 CARSGEN Therapeutics，Ltd
- 10.6.1 CARSGEN Therapeutics，Ltd Basic Information
- 10.6.2 CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Overview
- 10.6.3 CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Market Performance
- 10.6.4 CARSGEN Therapeutics，Ltd Business Overview
- 10.6.5 CARSGEN Therapeutics，Ltd Recent Developments
- 10.7 Juno Therapeutics
- 10.7.1 Juno Therapeutics Basic Information
- 10.7.2 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Overview
- 10.7.3 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Market Performance
- 10.7.4 Juno Therapeutics Business Overview
- 10.7.5 Juno Therapeutics Recent Developments
- 10.8 Kite Pharma
- 10.8.1 Kite Pharma Basic Information
- 10.8.2 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Overview
- 10.8.3 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Market Performance
- 10.8.4 Kite Pharma Business Overview
- 10.8.5 Kite Pharma Recent Developments
- 10.9 Atara Biotherapeutics
- 10.9.1 Atara Biotherapeutics Basic Information
- 10.9.2 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Overview
- 10.9.3 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Market Performance
- 10.9.4 Atara Biotherapeutics Business Overview
- 10.9.5 Atara Biotherapeutics Recent Developments
- 10.10 Carina Biotech
- 10.10.1 Carina Biotech Basic Information
- 10.10.2 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Overview
- 10.10.3 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Market Performance
- 10.10.4 Carina Biotech Business Overview
- 10.10.5 Carina Biotech Recent Developments
- 10.11 Guangzhou Xiangxue Pharmaceutical
- 10.11.1 Guangzhou Xiangxue Pharmaceutical Basic Information
- 10.11.2 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Overview
- 10.11.3 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Market Performance
- 10.11.4 Guangzhou Xiangxue Pharmaceutical Business Overview
- 10.11.5 Guangzhou Xiangxue Pharmaceutical Recent Developments
- 11 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast by Region
- 11.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Forecast
- 11.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Forecast by Country
- 11.2.3 Asia Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Forecast by Region
- 11.2.4 South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Type (2026-2033)
- 12.1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Type (2026-2033)
- 12.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast by Application (2026-2033)
- 12.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales (K Units) Forecast by Application
- 12.2.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
